Identification of novel DNA methylation markers in colorectal cancer using MIRA-based microarrays

Oncology Reports

Volumn 28, Issue 1, 2012, Pages 99-104

  Li, Hai ^a   Du, Yong ^a   Zhang, Dong ^a   Wang, Li Na ^a   Yang, Chun ^a   Liu, Bin ^a   Wang, Wei Jie ^a   Shi, Lei ^a   Hong, Wei Guo ^b   Zhang, Liang ^b   Yang, Yin Xue ^a  

^a NINGXIA MEDICAL UNIVERSITY   (China)

^b BioChain Beijing Science and Technology Inc   (China)

Author keywords

Colorectal cancer; CpG islands; DNA methylation analysis; Methyl CpG binding protein; Microarrays

Indexed keywords

VIMENTIN;

ARTICLE; COLORECTAL CANCER; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; DNA SEQUENCE; EARLY DIAGNOSIS; FGF12 GENE; GAD2 GENE; GENE AMPLIFICATION; GENE IDENTIFICATION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC SCREENING; GENETIC VARIABILITY; HUMAN; HUMAN TISSUE; MICROARRAY ANALYSIS; MIRA MICROARRAY ANALYSIS; NUCLEOTIDE SEQUENCE; ONCOGENE; PHOX2B GENE; PRIORITY JOURNAL; PROTEIN METHYLATION; RELIABILITY; TISSUE DIFFERENTIATION; TRANSCRIPTION REGULATION;

BASE SEQUENCE; CLUSTER ANALYSIS; COLORECTAL NEOPLASMS; CPG ISLANDS; DNA METHYLATION; FIBROBLAST GROWTH FACTORS; GLUTAMATE DECARBOXYLASE; HOMEODOMAIN PROTEINS; HUMANS; MOLECULAR SEQUENCE DATA; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; SEPTINS; SEQUENCE ANALYSIS, DNA; TRANSCRIPTION FACTORS; TUMOR MARKERS, BIOLOGICAL; VIMENTIN;

EID: 84861546354     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2012.1779     Document Type: Article

References (17)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J and Thun MJ: Cancer statistics, 2009. CA Cancer J Clin 59: 225-249, 2009.
2. Myers AP, Meyerhardt JA and Cantley LC: Getting knit-PI3Ky: PIK3CA mutation status to direct multimodality therapy? Clin Cancer Res 15: 6748-6750, 2009.
3. Schuebel KE, Chen W, Cope L, et al: Comparing the DNA hypermethylome with gene mutations in human colorectal cancer. PLoS Genet 3: 1709-1723, 2007. (Pubitemid 47510263)
4. Lofton-Day C, Model F, Devos T, et al: DNA methylation biomarkers for blood-based colorectal cancer screening. Clin Chem 54: 414-423, 2008. (Pubitemid 351302625)
5. Itzkowitz SH, Jandorf L, Brand R, et al: Improved fecal DNA test for colorectal cancer screening. Clin Gastroenterol Hepatol 5: 111-117, 2007. (Pubitemid 46096834)
6. Glockner SC, Dhir M, Yi JM, et al: Methylation of TFPI2 in stool DNA: a potential novel biomarker for the detection of colorectal cancer. Cancer Res 69: 4691-4699, 2009.
7. Houshdaran S, Hawley S, Palmer C, et al: DNA methylation profiles of ovarian epithelial carcinoma tumors and cell lines. PLoS One 5: e9359, 2010.
8. Rauch T, Li H, Wu X and Pfeifer GP: MIRA-assisted microarray analysis, a new technology for the determination of DNA methylation patterns, identifies frequent methylation of homeodomain-containing genes in lung cancer cells. Cancer Res 66: 7939-7947, 2006. (Pubitemid 44299157)
9. Pfeifer GP and Rauch TA: DNA methylation patterns in lung carcinomas. Semin Cancer Biol 19: 181-187, 2009.
10. Dunwell T, Hesson L, Rauch TA, et al: A genome-wide screen identifies frequently methylated genes in haematological and epithelial cancers. Mol Cancer 9: 44, 2010.
11. Hill VK, Hesson LB, Dansranjavin T, et al: Identification of 5 novel genes methylated in breast and other epithelial cancers. Mol Cancer 9: 51, 2010.
12. Rauch TA, Wu X, Zhong X, Riggs AD and Pfeifer GP: A human B cell methylome at 100-base pair resolution. Proc Natl Acad Sci USA 106: 671-678, 2009.
13. Rauch TA and Pfeifer GP: The MIRA method for DNA methylation analysis. Methods Mol Biol 507: 65-75, 2009.
14. Robinson MD, Stirzaker C, Statham AL, et al: Evaluation of affinity-based genome-wide DNA methylation data: effects of CpG density, amplification bias, and copy number variation. Genome Res 20: 1719-1729, 2010.
15. Bennett LB, Schnabel JL, Kelchen JM, et al: DNA hypermethylation accompanied by transcriptional repression in follicular lymphoma. Genes Chromosomes Cancer 48: 828-841, 2009.
16. Abbaszadeh F, Barker KT, McConville C, Scott RH and Rahman N: A new familial cancer syndrome including predisposition to Wilms tumor and neuroblastoma. Fam Cancer 9: 425-430, 2010.
17. de Pontual L, Trochet D, Bourdeaut F, et al: Methylation-associated PHOX2B gene silencing is a rare event in human neuroblastoma. Eur J Cancer 43: 2366-2372, 2007. (Pubitemid 350001247)